Annual Reports

 
Quarterly Reports

 
8-K

 
Other

  • 15-12G (Mar 5, 2015)
  • Form 4 (Feb 24, 2015)
  • SC TO-T (Feb 23, 2015)
  • Form 4 (Feb 20, 2015)
  • SC 13G (Feb 18, 2015)
  • SC 13G (Feb 17, 2015)
NPS Pharmaceuticals DEFA14A 2010

Documents found in this filing:

  1. Defa14A
  2. Defa14A

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

SCHEDULE 14A

(RULE 14a-101)

Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.     )

 

Filed by the Registrant  x

Filed by a Party other than the Registrant  o

Check the appropriate box:

o

Preliminary Proxy Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

o

Definitive Proxy Statement

x

Definitive Additional Materials

o

Soliciting Material Pursuant to §240.14a-12

 

NPS PHARMACEUTICALS, INC.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

x

No fee required.

o

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

(1)

Title of each class of securities to which transaction applies:

 

 

Not Applicable

 

(2)

Aggregate number of securities to which transaction applies:

 

 

Not Applicable

 

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

Not Applicable

 

(4)

Proposed maximum aggregate value of transaction:

 

 

Not Applicable

 

(5)

Total fee paid:

 

 

Not Applicable

 

 

o

Fee paid previously with preliminary materials.

 

 

o

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

(1)

Amount Previously Paid:

 

 

Not Applicable

 

(2)

Form, Schedule or Registration Statement No.:

 

 

Not Applicable

 

(3)

Filing Party:

 

 

Not Applicable

 

(4)

Date Filed:

 

 

Not Applicable

 



 

*** Exercise Your Right to Vote ***

 

Important Notice Regarding the Availability of Proxy Materials for the

Shareholder Meeting to Be Held on May 19, 2010

 

NPS PHARMACEUTICAL INC.

 

Meeting Information

 

Meeting Type: Annual Meeting

For holders as of: March 29, 2010

Date: May 19, 2010

Time: 2:00 PM EDT

Location:

The Bernards Inn

 

27 Mine Brook Road

 

Bernardsville, NJ 07924

 

You are receiving this communication because you hold shares in the above named company.

 

This is not a ballot.  You cannot use this notice to vote these shares.  This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).

 

We encourage you to access and review all of the important information contained in the proxy materials before voting.

 

See the reverse side of this notice to obtain proxy materials and voting instructions.

 

0000061373_1     R2.09.05.010

 



 

Before You Vote

How to Access the Proxy Materials

 

Proxy Materials Available to VIEW or RECEIVE:

1. Annual Report

2. Notice & Proxy Statement

 

How to View Online:

Have the 12-Digit Control Number available (located on the following page) and visit: www.proxyvote.com.

 

How to Request and Receive a PAPER or E-MAIL Copy:

If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:

 

1) BY INTERNET:

www.proxyvote.com

 

2) BY TELEPHONE:

1-800-579-1639

 

3) BY E-MAIL*:

sendmaterial@proxyvote.com

 


*  If requesting materials by e-mail, please send a blank e-mail with the 12-Digit Control Number (located on the following page) in the subject line.

 

Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before May 05, 2010 to facilitate timely delivery.

 

How To Vote

Please Choose One of the Following Voting Methods

 

Vote In Person: If you choose to vote these shares in person at the meeting, you must request a “legal proxy.” To do so, please follow the instructions at www.proxyvote.com or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.

 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the 12-Digit Control Number available and follow the instructions.

 

Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.

 

0000061373_2     R2.09.05.010

 


 


 

Voting items

 

The Board of Directors recommends that you vote FOR the following:

 

1.              Election of Directors

 

Nominees

 

01

Michael W. Bonney

02

Colin Broom

03

James G. Groninger

04

Donald E. Kuhla

05

Francois Nader

06

Rachel R. Selisker

07

Peter G. Tombros

 

The Board of Directors recommends you vote FOR the following proposal(s):

 

2                 To approve the adoption of the NPS Pharmaceuticals, Inc. 2010 Employee Stock Purchase Plan.

 

3                 To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2010.

 

NOTE: To transact such other business as may properly come before the meeting or any adjournment thereof.

 

0000061373_3    R2.09.05.010

 



 

Voting  Instructions

 

0000061373_4    R2.09.05.010

 


Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki